Skip to main content
Fig. 6 | Clinical Epigenetics

Fig. 6

From: Venetoclax confers synthetic lethality to chidamide in preclinical models with transformed follicular lymphoma

Fig. 6

Synthetic lethality of venetoclax/chidamide depends on the activation of mitochondrial pathway. The t-FL cell lines A DOHH2 and B SU-DHL-4 were exposed to indicated treatment for 48 h, after which mitochondrial membrane potential was measured using a JC-1 kit. Data were represented as the mean ± SD; the corresponding statistics are shown in C–F. ***p < 0.001, ****p < 0.0001 and ns (not significant) by one‐way ANOVA

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us